Department of Pharmacology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, P. M. B. 12003 Lagos, Nigeria.
Department of Pharmacology, Faculty of Basic Medical Sciences, College of Medicine, University of Lagos, P. M. B. 12003 Lagos, Nigeria.
Chin J Nat Med. 2013 Nov;11(6):628-37. doi: 10.1016/S1875-5364(13)60073-4.
Diabetes Mellitus is associated with significant morbidity and mortality worldwide. The need for enhanced efficacy and safety, and cheaper and more readily available new drugs has increased the search for new antidiabetic drugs from plants. This study was conducted to investigate the antidiabetic activity of the hydroethanolic leaf extract of B. coccineus in rats.
The effect of B. coccineus extract (100-800 mg · kg(-1), p.o.) on blood glucose levels in normal and glucose loaded rats, and alloxan-induced diabetic rats was determined. After 10 days of treatment, blood samples were collected from rats for lipid and insulin profiling. Animals were thereafter sacrificed and the kidneys, heart, and liver were harvested for antioxidant indices assay.
In normal rats, B. coccineus did not cause significant reduction in blood glucose. At the dose of 800 mg · kg(-1), significant increase in blood glucose level was not observed 30 min. after glucose load. B. coccineus administered acutely did not generally produce significant reduction in blood glucose level in diabetic rats. Administered subacutely, the extract significantly reduced blood glucose level in diabetic rats from the 3(rd) day with peak effect observed at the dose of 800 mg · kg(-1) on the 10(th) day. The extract generally preserved in vivo antioxidant levels in the kidneys, heart, and liver, increased the level of high density lipoprotein and insulin, and reduced the level of triglycerides and low density lipoprotein compared to diabetic control.
The findings in this study suggest that the hydroethanolic leaf extract Byrsocarpus coccineus possesses antidiabetic activity possibly mediated through inhibition of intestinal glucose absorption, in vivo antioxidant activity, and enhancement of regeneration of beta cells of the pancreas and insulin secretion.
糖尿病在全球范围内与显著的发病率和死亡率相关。为了提高疗效和安全性,以及寻找更便宜、更容易获得的新药,人们对植物来源的新型抗糖尿病药物的需求不断增加。本研究旨在研究可可树的水醇提叶提取物在大鼠中的抗糖尿病活性。
测定可可树提取物(100-800mg·kg(-1),po)对正常和葡萄糖负荷大鼠及链脲佐菌素诱导的糖尿病大鼠血糖水平的影响。治疗 10 天后,从大鼠采集血液样本进行脂质和胰岛素分析。然后处死动物,采集肾脏、心脏和肝脏进行抗氧化指标测定。
在正常大鼠中,可可树提取物并未显著降低血糖水平。在 800mg·kg(-1)剂量下,葡萄糖负荷 30 分钟后血糖水平未见显著升高。急性给予可可树提取物通常不会显著降低糖尿病大鼠的血糖水平。亚急性给予可可树提取物可显著降低糖尿病大鼠的血糖水平,从第 3 天开始,在第 10 天 800mg·kg(-1)剂量时达到峰值。与糖尿病对照组相比,该提取物一般可维持肾脏、心脏和肝脏的体内抗氧化水平,增加高密度脂蛋白和胰岛素水平,降低甘油三酯和低密度脂蛋白水平。
本研究结果表明,可可树的水醇提叶提取物具有抗糖尿病活性,可能通过抑制肠道葡萄糖吸收、体内抗氧化活性以及增强胰腺β细胞的再生和胰岛素分泌来介导。